Patents by Inventor Minerva SANCHEZ

Minerva SANCHEZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SYSTEMS AND METHODS FOR TREATING ALPHA 1-ANTITRYPSIN (A1AT) DEFICIENCY
    Publication number: 20240110179
    Abstract: CRISPR/RNA-guided nuclease-related compositions and methods for treatment of A1AT deficiency and associated conditions are disclosed.
    Type: Application
    Filed: November 28, 2022
    Publication date: April 4, 2024
    Applicant: EDITAS MEDICINE, INC.
    Inventors: Shen SHEN, Penrose O'DONNELL, Minerva SANCHEZ
  • Systems and methods for treating alpha 1-antitrypsin (A1AT) deficiency
    Patent number: 11512311
    Abstract: CRISPR/RNA-guided nuclease-related compositions and methods for treatment of A1AT deficiency and associated conditions are disclosed.
    Type: Grant
    Filed: March 24, 2017
    Date of Patent: November 29, 2022
    Assignee: EDITAS MEDICINE, INC.
    Inventors: Shen Shen, Penrose O'Donnell, Minerva Sanchez
  • SYSTEMS AND METHODS FOR TREATING ALPHA 1-ANTITRYPSIN (A1AT) DEFICIENCY
    Publication number: 20200216843
    Abstract: CRISPR/RNA-guided nuclease-related compositions and methods for treatment of A1AT deficiency and associated conditions are disclosed.
    Type: Application
    Filed: March 24, 2017
    Publication date: July 9, 2020
    Inventors: Shen SHEN, Penrose O'DONNELL, Minerva SANCHEZ